*ST Jiyou announced that the company plans to purchase a total of 50.76% of its shares in Jiangsu Huiju Pharmaceutical Co., Ltd. from Huang Hua, Zou Ping, Bi Weiguo, Nantong Huiping, and Nantong Huiyuan through cash payment, at a transaction price of 1,006 billion yuan. This transaction constitutes a major asset restructuring and related transaction, and does not constitute a restructuring and listing. After the transaction is completed, Huiju Pharmaceutical will become the company's holding subsidiary.

*ST Jiyou announced that the company plans to purchase a total of 50.76% of its shares in Jiangsu Huiju Pharmaceutical Co., Ltd. from Huang Hua, Zou Ping, Bi Weiguo, Nantong Huiping, and Nantong Huiyuan through cash payment, at a transaction price of 1,006 billion yuan. This transaction constitutes a major asset restructuring and related transaction, and does not constitute a restructuring and listing. After the transaction is completed, Huiju Pharmaceutical will become the company's holding subsidiary.